Michael Berman
Appearances
- DateMay 20, 2024BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form metabolic dysfunction-associated steatohepatitis (MASH) are highly prevalent worldwide. However, current non-invasive diagnostic approaches for MASLD and MASH are suboptimal…
Presenter
Speakers
University of California San DiegoThe Chinese University of Hong Kong